Answers are grounded in this paper and cite their sources.
Ceftolozane-tazobactam (C/T) is a combination of a cephalosporin and a β-lactamase inhibitor with activity against Gram-negative bacilli (GNB). The study aims were to evaluate the activity of C/T in vitro vs. comparators against clinical GNB isolated from Chinese paediatric patients.
No takes yet. Share an insight, caveat, or question.
Mu et al. (2024) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: